|
[1]
|
Wallace, Z.S., Naden, R.P., Chari, S., Choi, H., Della‐Torre, E., Dicaire, J., et al. (2020) The 2019 American College of Rheumatology/European League against Rheumatism Classification Criteria for IgG4‐Related Disease. Arthritis & Rheumatology, 72, 7-19. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Peyronel, F., Della-Torre, E., Maritati, F., Urban, M.L., Bajema, I., Schleinitz, N., et al. (2025) IgG4-Related Disease and Other Fibro-Inflammatory Conditions. Nature Reviews Rheumatology, 21, 275-290. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kawano, M. and Saeki, T. (2015) IgG4-Related Kidney Disease—An Update. Current Opinion in Nephrology and Hypertension, 24, 193-201. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Parums, D.V. (2025) IgG4-Related Disease: A Review of Persistent Challenges in the Pathogenesis, Diagnosis, and Approaches to Treatment. Medical Science Monitor, 31, e950212. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Arias-Intriago, M., Gomolin, T., Jaramillo, F., Cruz-Enríquez, A.C., Lara-Arteaga, A.L., Tello-De-la-Torre, A., et al. (2025) IgG4-Related Disease: Current and Future Insights into Pathological Diagnosis. International Journal of Molecular Sciences, 26, Article No. 5325. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Masamune, A., Kikuta, K., Hamada, S., Tsuji, I., Takeyama, Y., Shimosegawa, T., et al. (2020) Nationwide Epidemiological Survey of Autoimmune Pancreatitis in Japan in 2016. Journal of Gastroenterology, 55, 462-470. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Wallace, Z.S., Miles, G., Smolkina, E., Petruski-Ivleva, N., Madziva, D., Cook, C., et al. (2023) Incidence, Prevalence and Mortality of IgG4-Related Disease in the USA: A Claims-Based Analysis of Commercially Insured Adults. Annals of the Rheumatic Diseases, 82, 957-962. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Jha, I., McMahon, G.A., Perugino, C.A., Katz, G., Wallace, Z.S., Fernandes, A., et al. (2024) Sex as a Predictor of Clinical Phenotype and Determinant of Immune Response in IgG4-Related Disease: A Retrospective Study of Patients Fulfilling the American College of Rheumatology—European League against Rheumatism Classification Criteria. The Lancet Rheumatology, 6, e460-e468. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ko, J., Lee, M.J., Khwarg, S.I., Yoon, J.S., Yang, S., Son, J., et al. (2025) Immunoglobulin G4-Related Ophthalmic Disease. Ophthalmology, 132, 995-1004. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Wu, S., Qin, X., Jin, Z. and Yang, L. (2025) A Comprehensive Review of IgG4-Related Pancreatitis: Pathogenesis, Diagnosis, and Therapeutic Advances. Frontiers in Immunology, 16, Article ID: 1590902. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Beuers, U. and Trampert, D.C. (2025) IgG4-Related Cholangitis. Seminars in Liver Disease, 45, 381-396. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Kawano, M. (2025) Update on IgG4-Related Periaortitis/Retroperitoneal Fibrosis and Periarteritis-Recent Clinical, Diagnostic and Therapeutic Advances. Seminars in Arthritis and Rheumatism, 72, Article ID: 152691. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ghaffari Jolfayi, A., Salmanipour, A., Heshmat-Ghahdarijani, K., Meshgi, S., Dastmardi, M., Salehabadi, G., et al. (2025) Imaging Findings in Cardiovascular Involvements of IgG4-Related Disease: A Systematic Review Study. Rheumatology, 64, 943-951. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Ebrahimi, N., Ha, V., Whittier, W., Efe, O., Kronbichler, A., Grace Choung, H.Y., et al. (2025) IgG4-Related Kidney Disease. Clinical Journal of the American Society of Nephrology, 20, 588-590. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Kawano, M., Saeki, T., Ubara, Y. and Matsui, S. (2023) Recent Advances in IgG4-Related Kidney Disease. Modern Rheumatology, 33, 242-251. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Petelytska, L., Nikitina, A., Tarasenko, O., Chechotenko, I., Mykhailov, D., Kravchenko, V., et al. (2023) IgG4-Related Retroperitoneal Fibrosis with Acute Kidney Injury: A Case Report and Literature Review. Rheumatology International, 43, 2141-2153. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Okamoto, A., Watanabe, T., Kamata, K., Minaga, K. and Kudo, M. (2019) Recent Updates on the Relationship between Cancer and Autoimmune Pancreatitis. Internal Medicine, 58, 1533-1539. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Shiokawa, M., Kodama, Y., Yoshimura, K., Kawanami, C., Mimura, J., Yamashita, Y., et al. (2013) Risk of Cancer in Patients with Autoimmune Pancreatitis. American Journal of Gastroenterology, 108, 610-617. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Wallace, Z.S., Naden, R.P., Chari, S., Choi, H.K., Della-Torre, E., Dicaire, J., et al. (2020) The 2019 American College of Rheumatology/European League against Rheumatism Classification Criteria for IgG4-Related Disease. Annals of the Rheumatic Diseases, 79, 77-87. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ichiki, A., Hashimoto, N., Ueda, T., Hiraiwa, S., Tajiri, T., Nakamura, N., et al. (2016) IgG4-Related Disease with Bone Marrow Involvement. Internal Medicine, 55, 2295-2299. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Shimazu, Y., Uchiyama, T., Mizumoto, C., Takeoka, T., Tsuji, M., Tomo, K., et al. (2018) Concurrent Autoimmune Neutropenia and Idiopathic Thrombocytopenic Purpura Associated with IgG4-Related Disease. Internal Medicine, 57, 1911-1916. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Peyronel, F. and Vaglio, A. (2023) IgG4-Related Kidney Disease. Clinical Journal of the American Society of Nephrology, 18, 994-996. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Stone, J.H. (2025) IgG4-Related Disease: Lessons from the First 20 Years. Rheumatology, 64, i24-i27. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Raissian, Y., Nasr, S.H., Larsen, C.P., Colvin, R.B., Smyrk, T.C., Takahashi, N., et al. (2011) Diagnosis of IgG4-Related Tubulointerstitial Nephritis. Journal of the American Society of Nephrology, 22, 1343-1352. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
张文, 董凌莉, 朱剑, 等. IgG4相关性疾病诊治中国专家共识[J]. 中华内科杂志, 2021, 60(3): 192-206.
|
|
[26]
|
Umehara, H., Okazaki, K., Kawa, S., Takahashi, H., Goto, H., Matsui, S., et al. (2021) The 2020 Revised Comprehensive Diagnostic (RCD) Criteria for IgG4-rd. Modern Rheumatology, 31, 529-533. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Tsuge, S., Fujii, H., Tamai, M., Tsujiguchi, H., Yoshida, M., Suzuki, N., et al. (2024) Factors Related to Elevated Serum Immunoglobulin G4 (IgG4) Levels in a Japanese General Population. Arthritis Research & Therapy, 26, Article No. 156. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
费允云, 刘燕鹰, 董凌莉, 等. IgG4相关性疾病诊疗规范[J]. 中华内科杂志, 2023, 62(10): 1161-1171.
|
|
[29]
|
Khosroshahi, A., Wallace, Z.S., Crowe, J.L., Akamizu, T., Azumi, A., Carruthers, M.N., et al. (2015) International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease. Arthritis & Rheumatology, 67, 1688-1699. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Stone, J.H., Khosroshahi, A., Zhang, W., Della Torre, E., Okazaki, K., Tanaka, Y., et al. (2025) Inebilizumab for Treatment of IgG4-Related Disease. New England Journal of Medicine, 392, 1168-1177. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Chen, Y., Ye, C., Yang, P., Zhang, W., Dai, L., Wei, W., et al. (2025) Thalidomide Can Effectively Prevent Relapse in IgG4-Related Disease Outweighing Its Side Effects: A Multicentre, Randomised, Double-Blinded, Placebo-Controlled Study. Annals of the Rheumatic Diseases, 84, 1246-1252. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Yan, S., Peng, Y., Xu, J., et al. (2025) Genome-Wide Association Studies Reveal New Insights into the Genetic Basis of IgG4-Related Disease in the Chinese Han Population. Annals of the Rheumatic Diseases, 85, 693-703.
|
|
[33]
|
Sasaki, T., Akiyama, M., Kaneko, Y., et al. (2018) Risk Factors of Relapse Following Glucocorticoid Tapering in IgG4-Related Disease. Clinical and Experimental Rheumatology, 36, 186-189.
|
|
[34]
|
Ji, Z.F., Ma, L.Y., Zhang, L.J., et al. (2021) Prognostic Factors in IgG4-Related Disease: A Long-Term Monocentric Chinese Cohort Study. Clinical Rheumatology, 40, 2293-2300. [Google Scholar] [CrossRef] [PubMed]
|